Sign In
Buy IHE
$101.62
-0.84 (-0.82%)
At Close: Jul 31, 2026
2 ETFs to Watch for Outsized Volume on Short-Term Treasuries & Healthcare
08:17am, Thursday, 02'nd Jun 2022
BIL and IHE both ETFs had traded in an outsized volume yesterday.
Pharma ETFs in Focus Post Q1 Earnings
12:48pm, Thursday, 12'th May 2022
Many industry bigwigs reported solid results with some beating on earnings or revenues or both.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:32am, Tuesday, 10'th May 2022
Sector ETF report for IHE
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:32am, Tuesday, 08'th Mar 2022
Sector ETF report for IHE
Solid Q4 Earnings Fail to Impress Pharma ETFs
01:50pm, Tuesday, 22'nd Feb 2022
Solid earnings failed to impress pharma ETFs over the past month due to a broad sell-off in the market.
Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit
09:14am, Tuesday, 11'th Jan 2022
Pfizer is likely to launch Omicron vaccine in March while Moderna is working on a booster that targets the omicron variant of Covid-19.
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:43am, Thursday, 06'th Jan 2022
Sector ETF report for IHE
VIX and Biotech ETFs Invigorated Amid Pfizer COVID Pill News
06:29pm, Wednesday, 22'nd Dec 2021
Just when it seemed like the Omicron coronavirus variant might overshadow the traditional Santa Claus Rally, and stocks might be due for a deeper sell-off, equities gained momentum, bouncing for a sec
Top ETF Stories of November
02:33pm, Wednesday, 01'st Dec 2021
The emergence of the Omicron variant of Covid-19 and inflationary pressure were key highlights of the broader market in November.
ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus
02:36pm, Monday, 29'th Nov 2021
The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
11:28am, Tuesday, 09'th Nov 2021
The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.
Travel and Leisure ETFs Surge Amid Positive Jobs Data
06:09pm, Friday, 05'th Nov 2021
Travel and leisure stocks and ETFs are making major moves on Friday, following a better-than-expected October jobs report, and a fresh development in the coronavirus battle boosting enthusiasm for t
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:40am, Wednesday, 03'rd Nov 2021
Sector ETF report for IHE
Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan
02:03pm, Tuesday, 07'th Sep 2021
The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.
Pharma ETFs Gain on Q2 Earnings
11:30am, Friday, 06'th Aug 2021
Many industry bigwigs reported solid results with some beating on earnings or revenues or both.
